Successful Combination Therapy with Phototherapy and Topical Corticosteroid in a Rare Case : 57 Years Old Male Patient with Lichen Amyloidosis
DOI:
https://doi.org/10.26911/theijmed.2024.09.04.08Abstract
Background: : Lichen Amyloidosis (LA) is one of the most common forms of primary localized cutaneous amyloidosis, with clinical manifestations of itchy blackish brown hyperkeratotic papules. The most predilection site is the upper extensor of the legs. This case report aims to improve the clinician’s knowledge regarding clinical features and supporting examinations to the provision of appropriate therapy in LA.
Case Report: A 57 years old farmer presented to dermatology and venereology outpatient clinic of Dr. Moewardi general hospital with itchy black spots on nearly all over his body since 2 years ago. Dermatology examination obtained generalized papules and scaly hyperpigmented patches. Dermoscopy revealed a scar-like center with a whitish color in the center. Histopathological examination showed an amorphous eosinophilic (amyloid) in the dermis. Congo red examination demonstrated a reddish-orange amyloid. We treated the patient with oral cetirizine 10 mg/day, desoximetasone 0.25% cream applied twice a day in the morning and in the evening, Carmed® cream 20% cream applied twice a day in the afternoon and night, phototherapy 350 MJ/cm2 twice a week. We observed for 14 weeks. The lesion and itching started improving in week 8.
Result: Lichen amyloidosis is resulted from amyloid deposits in the papillary dermis which are derived from degradation of basal keratinocytes. The diagnosis is based on history taking, clinical examination, dermoscopy and skin biopsy. The combination of phototherapy and topical corticosteroid can be an option for LA therapy, especially for the symptom of pruritus.
Conclusion: Lichen Amyloidosis is the most common type of primary localized cutaneous amyloidosis, presents as blackish brown hyperkeratotic papules. The combined therapy of topical corticosteroids and phototherapy can significantly improve pruritus and skin lesions.
Keywords:
hyaluronic acid, knee, osteoarthritis, secretomeReferences
Abate M, Vanni D, Pantalone A, Salini V (2017). Hyaluronic acid in knee osteoarthritis: preliminary results using a four months administration schedule. Int J Rheumatic Dis. 20(2): 199–202. https://doi.org/10.1111/1756-185x.12572.
Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E (2016) Product Diffe-rences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee. Am J Sports Med. 44(8): 2158–2165. https://doi.org/10.1177/0363546515-609599.
Amo C del, Perez-Valle A, Atilano L, Andia I (2022). Unraveling the signaling secretome of platelet-rich plasma: Towards a better understanding of its therapeutic potential in knee osteo-arthritis. J Clin Med. 11(3): 473. https://doi.org/10.3390/jcm11030473.
Amodeo G, Niada S, Moschetti G, Franchi S, Savadori P, Brini AT, Sacerdote P (2021). Secretome of human adipose-derived mesenchymal stem cell relieves pain and neuroinflammation independently of the route of admi-nistration in experimental osteoarth-ritis. Brain Behav Immun. 94: 29-40. https://doi.org/10.1016/j.bbi.2021.03.011.
Anitua E, Sánchez M, Orive G, Andia I (2007). The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 28(31): 4551-60. https:-//doi.org/10.1016/j.biomaterials.2007.06.037.
Antony J, McGuinness K, O’Connor NE, Moran K (2016). Quantifying radio-graphic knee osteoarthritis severity using deep convolutional neural networks. In: 2016 23rd International Conference on Pattern Recognition (ICPR), December 2016: 1195–1200.
Ayhan E, Kesmezacar H, Akgun I (2014) Intraarticular injections (corticoste-roid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthoped. 5(3): 351-361. https://doi.org/10.5312/wjo.v5.i3.351
Bousnaki M, Bakopoulou A, Kritis A, Koidis P (2020). The efficacy of stem cells secretome application in osteo-arthritis: A systematic review of in vivo studies. Stem Cell Rev Rep. 16(6): 1222-1241. https://doi.org/10.1007/s12015-020-09980-x.
Charlesworth J, Fitzpatrick J, Perera NKP, Orchard J (2019). Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet Disord. 20(1): 151. https://doi.org/10.1186/-s12891-019-2525-0.
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H (2020a). Global, regional preva-lence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29–30. https://doi.org/10.1016/j.eclinm.2020.100587.
D’arrigo D, Roffi A, Cucchiarini M, Moretti M, Candrian C, Filardo G (2019). Se-cretome and Extracellular Vesicles as New Biological Therapies for Knee Osteoarthritis: A Systematic Review. J Clin Med. 8(11): 1867. https://doi.org/10.3390/jcm8111867.
Delgado DA, Lambert BS, Boutris N, et al. (2018). Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2(3): e088. https://doi.org/10.5435/jaaosglobal-d-17-00088.
Gigis I, Fotiadis E, Nenopoulos A, et al. (2016). Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Hippokratia. 20(1): 26–31. https://pmc.-ncbi.nlm.nih.gov/articles/PMC5074393/.
Gupta A (2022). Autologous adipose tissue vs. platelet-rich plasma for treatment of knee osteoarthritis. Biomedicines. 10(10):2527. https://doi.org/10.3390-/biomedicines10102527.
Gupta RC, Lall R, Srivastava A, Sinha A (2019). Hyaluronic acid: Molecular mechanisms and therapeutic trajec-tory. Front Vet Sci. 6:192. https://-doi.org/10.3389/fvets.2019.00192.
Hafez AR, Alenazi AM, Kachanathu SJ, Alroumi AM, Mohamed ES (2014). Knee osteoarthritis: A review of literature. Phys Med Rehabil Int. 1(5): 8. https://austinpublishinggroup.com/physical-medicine/fulltext/pmr-v1-id1021.php.
He Y, Li Z, Alexander PG, Ocasio-Nieves BD, Yocum L, Lin H, Tuan RS (2020). Pathogenesis of osteoarthritis: Risk factors, regulatory pathways in chondrocytes, and experimental models. Biology. 9(8): 194. https://doi.org/-10.3390/biology9080194.
Hochberg MC, Altman RD, April KT, Ben-khalti M, Guyatt G, McGowan J, Towheed T, et al. (2012). American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
Arthritis Care & Research 64(4): 465–474. https://doi.org/10.1002/acr.21596.
Hunter DJ and Bierma-Zeinstra S (2019a). Osteoarthritis. Lancet. 393(10182): 1745-1759. https://doi.org/10.1016/-s0140-6736(19)30417-9.
Iijima H, Isho T, Kuroki H, et al. (2018). Effectiveness of mesenchymal stem cells for treating patients with knee osteoarthritis: a meta-analysis toward the establishment of effective regenerative rehabilitation. NPJ Regen Med. 3(1): 15. https://doi.org/10.1038/s41536-018-0041-8.
Jang S, Lee K, Ju JH (2021). Recent updates of diagnosis, pathophysio-logy, and treatment on osteoarthritis of the knee. Int J Mol Sci. 22(5):2619. https://doi.org/10.3390/ijms22052619.
Kim YS, Suh DS, Tak DH, Chung PK, Kwon YB, Kim TY, Koh YG (2020). Compa-rative matched-pair cohort analysis of the short-term clinical outcomes of mesenchymal stem cells versus hyaluronic acid treatments through intra-articular injections for knee osteoarthritis. J Exp Orthop. 7(1):90. https://doi.org/10.1186/s40634-020-00310-1.
Kohn MD, Sassoon AA, Fernando ND (2016). Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis. Clin Orthop Relat Res. 474(8): 1886–1893. https://doi.org/10.1007/s11999-016-4732-4.
Koiri SP, Yang Y, Kui H (2018). Hyaluronic acid in the treatment of knee osteo-arthritis: Review. Yangtze Medicine. 02(02): 62–72. https://doi.org/10.42-36/ym.2018.22007.
Lopa S, Colombini A, Moretti M, de Giro-lamo L (2019). Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences. Knee Surg Sports Traumatol Arthrosc. 27(6): 2003-2020. https://doi.org/-10.1007/s00167-018-5118-9.
Maheu E, Zaim M, Appelboom T, Jeka S, Trc T, Berenbaum F, Maasalu K, et al. (2011). Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, pros-pective, randomized, controlled trial. Clin Exp Rheumatol. 29(3): 527–35. https://pubmed.ncbi.-nlm.nih.gov/21722501/.
Migliore A (2015). Effectiveness and utility of hyaluronic acid in osteoarthritis. Clin Cases Miner Bone Metab. 12(1): 31-3. https://doi.org/10.11138/ccmb-m/2015.12.1.031.
Miller LE, Bhattacharyya S, Parrish WR, Fredericson M, Bisson B, Altman RD (2021). Safety of intra-articular hyaluronic acid for knee osteo-arthritis: Systematic review and meta-analysis of randomized trials involving more than 8,000 patients. Cartilage. 13(1): 351S-363S. https://doi.org/10.1177/-1947603519888783.
Műzes G, Sipos F (2022). Mesenchymal stem cell-derived secretome: A potential therapeutic option for auto-immune and immune-mediated inflammatory diseases. Cells. 11(15): 2300. https://doi.org/10.3390/cells11152300.
Nabavizadeh SS, Talaei-Khozani T, Zarei M, Zare S, Hosseinabadi OK, Tanideh N, Daneshi S (2021). Attenuation of osteoarthritis progression via a com-bination of intra-articular injection of synovial membrane-derived MSCs (SMMSCs), platelet rich plasma (PRP) and conditioned medium (Secretome). J Orthop Surg Res. https://doi.org/10.1186/s13018-021-02851-2.
Partan RU, Putra KM, Kusuma NF, Darma S, Reagan M, Muthia P, Radiandina AS, et al. (2023). Umbilical cord mesenchymal stem cell secretome improves clinical outcomes and changes biomarkers in knee osteo-arthritis. J Clin Med. 12(22):7138. https://doi.org/10.3390/jcm12227138.
Rachmat N, Janmo Minulyo A, Zubaidi A (2021). An overview of the quality of life of knee osteoarthritis patients at the surakarta orthopedic hospital. Jurnal Keterapian Fisik. 6(1): 38–48. https://doi.org/10.37341/jkf.v0i0.271
Ramkumar PN, Harris JD, Noble PC (2015) Patient-reported outcome measures after total knee arthroplasty. Bone Joint Res. 4(7): 120–127. https://doi.-org/10.1302/2046-3758.47.2000380.
Roos EM, Toksvig-Larsen S (2003). Health and quality of life outcomes knee injury and osteoarthritis outcome score (KOOS)-validation and compa-rison to the WOMAC in total knee replacement. Health Qual Life Out-comes. 1: 17. https://doi.org/10.1186-/1477-7525-1-17.
Saccomano SJ (2018). Osteoarthritis treat-ment. The Nurse Practitioner 43(9): 49–55. https://doi.org/10.1097/01.n-pr.0000544281.05010.86.
Salaffi F, Carotti M, Stancati A, Grassi W (2003). Radiographic assessment of osteoarthritis: Analysis of disease progression. Aging Clin Exp Res. 15(5): 391–404. https://doi.org/10.1007/bf-03327360.
Samma L, Rasjad C, Prihantono, Seweng A, Haryasena, Latief J, Bausat A, et al. (2021). Correlation between body mass index (BMI), visual analogue scale (VAS) score and knee osteo-arthritis grading. Medicina Clínica Práctica. 4(1): 100228. https://doi.-org/10.1016/j.mcpsp.2021.100228.
Santilli V (2016). Hyaluronic acid in the management of osteoarthritis: injec-tion therapies innovations. Clin Cases Miner Bone Metab. 13(2):131–134. https://doi.org/10.11138/ccmbm/2016.13.2.131.
Schelbergen RF, van Dalen S, ter Huurne M, Roth J, Vogl T, Noël D, Jorgensen C, et al. (2014). Treatment efficacy of adipose-derived stem cells in experi-mental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteo-arthritis Cartilage 22(8): 1158–1166. https:-//doi.org/10.1016/j.joca.2014.05.022.
Sharma L (2021) Osteoarthritis of the Knee. N England J Med. 384(1): 51–59. https://doi.org/10.1056/nejmcp1903768.
Shimizu H, Shimoura K, Iijima H, Suzuki Y, Aoyama T (2022). Functional manifestations of early knee osteoarthritis: a systematic review and meta-analysis. Clinical Rheumatology 41(9): 2625–2634. https://doi.org/10.1007/s10067-022-06150-x.
Shoukrie SI, Venugopal S, Dhanoa RK, et al. (2022). Safety and efficacy of injecting mesenchymal stem cells into a human knee joint to treat osteo-arthritis: A systematic review. Cureus. 14(5): e24823. https://doi.org/10.77-59/cureus.24823.
Sopiyudin Dahlan (2009). Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan. Jakarta: Salemba Medika.
Tamer TM (2013). Hyaluronan and syno-vial joint: function, distribution and healing. Interdisciplinary Toxicology 6(3): 111–125. https://pubmed.ncbi.-nlm.nih.gov/24678248/.
Teixeira FG, Carvalho MM, Sousa N, Salgado AJ (2013). Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?. Cell Mol Life Sci. 70(20): 3871–3882. https://doi.org/10.1007/s00018-013-1290-8.
Wang YC, Lee CL, Chen YJ, Tien YC, Lin SY, Chen CH, Chou PPH, Huang HT (2022) Comparing the efficacy of intra-articular single platelet-rich plasma (PRP) versus novel cross-linked hyaluronic acid for early-stage knee osteoarthritis: A prospective, double-blind, randomized controlled trial. Medicina (Kaunas). 58(8): 1028. https://doi.org/10.3390/medicina58081028.
Wasterlain AS, Braun HJ, Harris AHS, Kim HJ, Dragoo JL (2012). The systemic effects of platelet-rich plasma injection. Am J Sports Med. 41(1): 186-93. https://doi.org/10.1177/0363546512-466383.
Zhang H, Zhang K, Zhang X, Zhu Z, Yan S, Sun T, Guo A, et al. (2015) Compa-rison of two hyaluronic acid formula-tions for safety and efficacy (CHASE) study in knee osteoarthritis: a multi-center, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz. Arthritis Research & Therapy 17(1): 51. https://doi.org/10.1186/s13075-015-0557-x.
